GLP-3+CAGRILINTIDE

GLP-3 (RETA) + CAGRILINTIDE is a triple-agonist peptide that activates GLP-1, GIP, and glucagon receptors, producing effects on appetite suppression, insulin sensitivity, and energy expenditure. Cagrilintide is a long-acting amylin analog studied for its ability to further enhance satiety and slow gastric emptying through amylin and calcitonin receptor activity.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.